Trimedyne Reports Its Financial Results for Its Fiscal Year Ending on September 30, 2017
03 janv. 2018 09h00 HE
|
Trimedyne, Inc.
IRVINE, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) -- TRIMEDYNE, INC. (OTCPINK “TMED”) today reported its financial results for its Fiscal Year ending on September 30, 2017. For the Fiscal Year Ended...
Trimedyne Reports Sales and Profit for The Quarter and Fiscal Year Ended September 30, 2006
26 déc. 2006 11h00 HE
|
Trimedyne, Inc.
LAKE FOREST, Calif., Dec. 26, 2006 (PRIME NEWSWIRE) -- Trimedyne, Inc. (OTCBB:TMED) today reported a profit of $97,000 or $0.01 per share on revenues of $6,237,000 for its fiscal year ended September...
Trimedyne Reports Revenue and Profit for the Quarter Ended March 31, 2004
21 mai 2004 10h00 HE
|
Trimedyne, Inc.
IRVINE, Calif., May 21, 2004 (PRIMEZONE) -- Trimedyne, Inc. (OTCBB:TMED) today reported a net profit of $149,000 or $0.01 per share, fully diluted, on net revenues from sales and other income...
Trimedyne's Laser And Re-Usable Optical Fibers Now Eligible For New, Higher Medicare Reimbursement
03 mai 2004 10h00 HE
|
Trimedyne, Inc.
IRVINE, Calif., May 3, 2004 (PRIMEZONE) -- Trimedyne, Inc. (OTCBB:TMED) today announced its 80 Watt Holmium Laser and Re-usable Optical Fibers are eligible for Medicare's new reimbursement rate for...
Trimedyne Featured on CEO/CFO Interviews
31 mars 2004 14h24 HE
|
Trimedyne, Inc.
IRVINE, Calif., March 31, 2004 (PRIMEZONE) -- Trimedyne, Inc. (OTCBB:TMED) today announced that Marvin P. Loeb, Chairman of Trimedyne, was interviewed by Diane Reynolds of CEO/CFO Interviews. A...
Trimedyne Announces U.S. Patent Office Allowance of Patent to Treat Blocked Coronary Arteries
15 mars 2004 10h00 HE
|
Trimedyne, Inc.
IRVINE, Calif., March 15, 2004 (PRIMEZONE) -- Trimedyne, Inc. (OTCBB:TMED) today announced the U.S. Patent Office has allowed 24 claims of its patent application on a new Laser Angioplasty Catheter...
Trimedyne Receives U.S. Patent Office Allowance of Important Patent to Treat Heart Valve Malfunction
04 mars 2004 10h00 HE
|
Trimedyne, Inc.
IRVINE, Calif., March 4, 2004 (PRIMEZONE) -- Trimedyne, Inc. (OTCBB:TMED) today announced the U.S. Patent Office has allowed 17 claims of its patent application on a new Laser Balloon Catheter...
Trimedyne's Chairman Interviewed by Wall Street Reporter
04 févr. 2004 10h00 HE
|
Trimedyne, Inc.
IRVINE, Calif., Feb. 4, 2004 (PRIMEZONE) -- Trimedyne, Inc. (OTCBB:TMED) today announced its Chairman, Marvin P. Loeb, was interviewed by Ian Roberts of the Wall Street Reporter. The audio interview...
Trimedyne Featured on MacReport.Net
28 janv. 2004 10h30 HE
|
Trimedyne, Inc.
IRVINE, Calif., Jan. 28, 2004 (PRIMEZONE) -- Trimedyne, Inc. (OTCBB:TMED) today announced its chairman, Marvin P. Loeb, was interviewed by MacReport.Net. The interview will be available by visiting...
Trimedyne Reports Revenues and Profits for the Quarter and Fiscal Year Ended September 30, 2003
14 janv. 2004 10h00 HE
|
Trimedyne, Inc.
IRVINE, Calif, Jan. 14, 2004 (PRIMEZONE) -- Trimedyne, Inc. (OTCBB:TMED) today reported a net profit of $1,034,000 or $0.08 per share ($0.07 per share fully diluted) on revenues of $6,459,000 for the...